Arformoterol in 2026: Is There Really a Shortage?

If you've been struggling to fill your Arformoterol prescription, you're probably wondering: is there an actual shortage, or is something else going on?

The short answer is that Arformoterol (brand name Brovana) is not currently listed on the FDA's official drug shortage database as of early 2026. But that doesn't mean finding it is easy. Many COPD patients are reporting difficulty locating this nebulized medication at their local pharmacies — and there are real reasons behind those challenges.

Here's what's actually happening with Arformoterol availability in 2026 and what you can do about it.

Is Arformoterol Still in Shortage?

No — at least not in the traditional sense. The FDA tracks drug shortages and publishes an active list of medications with known supply problems. As of March 2026, Arformoterol does not appear on that list.

However, practical availability at the pharmacy level is a different story. Drug shortages hit all-time highs in 2024, with over 300 medications affected nationally. While Arformoterol wasn't one of the formally listed drugs, the ripple effects of those widespread shortages — combined with Arformoterol's niche status — have made it harder to find in many areas.

The bottom line: the medication is being manufactured, but getting it into your hands takes more effort than it should.

Why Is Arformoterol Hard to Find?

Several factors are working against patients trying to fill their Arformoterol prescriptions in 2026:

Limited Demand Means Limited Stocking

Arformoterol is one of only two nebulized LABAs on the market (the other is Perforomist). Most COPD patients use handheld inhalers, so the number of people on nebulized Arformoterol is relatively small. Many pharmacies — especially chain locations — don't keep it in stock because they rarely dispense it.

Supply Chain Lingering Effects

The pharmaceutical supply chain disruptions of 2023–2024 created lasting effects. Even medications not directly in shortage can be harder to source as wholesalers and pharmacies adjust their inventory strategies. Smaller-volume medications like Arformoterol are often the first to be dropped from standard stock lists.

Insurance Barriers

Many insurance plans require prior authorization for Arformoterol. Some implement step therapy, meaning you must try (and fail) a less expensive alternative first. These requirements create delays that can feel like the medication is unavailable when it's really an access issue.

For a deeper dive into why this medication is difficult to find, read why Arformoterol is so hard to find in 2026.

What Does Arformoterol Cost in 2026?

Cost is a major piece of the availability puzzle. Here's what you can expect to pay:

• Brand-name Brovana: $456 to $1,045 for a 30-day supply (60 vials) without insurance
• Generic Arformoterol Tartrate: $66 to $125 for 30 vials at retail prices
• With SingleCare coupon: As low as $47.87 for 30 vials
• With GoodRx coupon: As low as $77.32 for 60 vials

Generic Arformoterol is available and significantly cheaper than brand-name Brovana. If cost is a barrier, using a prescription discount card can cut your out-of-pocket expense dramatically.

For the full breakdown on saving money, see our complete guide: how to save money on Arformoterol in 2026.

Are There New Options for COPD Patients in 2026?

The COPD treatment landscape continues to evolve. While Arformoterol remains an important option for patients who need nebulized therapy, here are some developments worth knowing about:

• Generic availability: Generic Arformoterol Tartrate inhalation solution is available from multiple manufacturers, increasing supply and lowering costs.
• Combination therapies: Newer COPD treatments combine a LABA with a long-acting muscarinic antagonist (LAMA) in a single device. Examples include Stiolto Respimat (Olodaterol/Tiotropium) and Anoro Ellipta (Vilanterol/Umeclidinium).
• Telehealth prescribing: If you're having trouble getting an appointment with a pulmonologist, telehealth visits can help you get or maintain your Arformoterol prescription. Learn more about finding a doctor who prescribes Arformoterol.

If you're considering a switch, our article on alternatives to Arformoterol covers your options in detail.

How to Find Arformoterol in Stock Right Now

Here's a step-by-step action plan:

1. Check Medfinder: Visit Medfinder and search for Arformoterol with your zip code. You'll see which pharmacies near you have it in stock.
2. Try independent pharmacies: Independent and specialty pharmacies are more likely to carry niche nebulizer medications or order them quickly.
3. Ask for a special order: Most pharmacies can order Arformoterol through their wholesaler within 1–2 business days.
4. Consider mail-order: Your insurance plan's mail-order pharmacy may have more reliable inventory for maintenance medications.
5. Talk to your doctor: If you consistently can't find Arformoterol, your prescriber can help identify pharmacies, adjust your prescription, or recommend alternatives.

For more detailed tips, read our guide on how to find Arformoterol in stock near you.

Final Thoughts

Arformoterol is not in a formal FDA-recognized shortage in 2026, but real-world availability challenges continue to frustrate COPD patients. The issues are driven by limited pharmacy stocking, lingering supply chain disruptions, and insurance access barriers — not by a lack of manufacturing.

The most important thing is to stay proactive. Use tools like Medfinder, build a relationship with a pharmacy that stocks your medication, and work closely with your healthcare provider to ensure you never run out. Your breathing depends on it.